What’s New at TrialX! 🚀 Congratulations to the Reflections Collective Team! They won the Fierce DEI Awards in the Community Engagement and Outreach category, announced at the Patients as Partners Europe conference in London this month. True to its name,…
For decades, clinical trials have struggled with a deep-rooted problem: a lack of diversity. Racial and ethnic minorities, individuals in non-English-speaking communities, and patients outside of research-heavy geographies remain consistently underrepresented in studies. This isn’t just…
Sickle Cell Disease (SCD) is a complex genetic disorder affecting the production of hemoglobin that causes red blood cells to deform into a sticky rigid, sickle shape. This leads to severe complications, such as pain, organ…
Key Takeaways from SCOPE Summit 2025 Patient-Centricity is Non-Negotiable: Trials must prioritize patient needs, reduce burdens, and improve engagement to succeed. AI and Digital Health are Game-Changers: From protocol design to patient matching, AI is transforming…
Recruiting participants for clinical trials remains a significant challenge for sponsors. They often face inefficiencies that cause delays or trial failures, with up to 86% of trials experiencing recruitment difficulties. These delays incur millions of dollars…
World Pancreatic Cancer Day just passed, reminding us of the urgent need to support individuals and families affected by this challenging disease. We are proud to partner with Let’s Win Pancreatic Cancer to launch its innovative global Clinical…
With 7.5+ billion people across the globe, humans come in various hues. And while we have a lot in common, we are unique in genetics, food habits, race, ethnicity, culture and language among many others. In…
